Research Article
Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study
Table 4
Comparison of blood renal parameters in 3 age groups.
| | Study group | Deferoxamine | Deferasirox | Control | Mean ± SD | Mean ± SD | Mean ± SD | value |
| Age | Under 18 years old () | GFR | | | — | 0.159 | BUN | | | | 0.161 | CREA | | | | 0.048 | Cystatin C | | | | 0.593 | GFR based on Cystatin | | | | 0.416 | 18 to 25 years old () | GFR | | | | 0.053 | BUN | | | | 0.002 | CREA | | | | 0.103 | Cystatin C | | | | 0.159 | GFR based on Cystatin | | | | 0.166 | 25 to 35 years old () | GFR | | | | 0.038 | BUN | | | | 0.213 | CREA | | | | 0.137 | Cystatin C | | | | 0.233 | GFR based on Cystatin | | | | 0.233 |
|
|
Kruskal-Wallis test; ANOVA test; GFR: glomerular filtration rate; BUN: blood urea nitrogen; CREA: creatinine. |